(Total Views: 168)
Posted On: 11/16/2023 7:37:24 AM
Post# of 23611
NASDAQ : $PIII INSTITUTIONAL EQUITY RESEARCH |
November 9, 2023
P3 Health Partners Inc. Buy (PIII – $1.31) Price Target: $9 3Q A Bit Light But Primarily Due To The Timing Of Sweeps, Affirms Guidance For 2023, Sees $20M+ Of Positive AEBITDA For 2024; Affirm Buy Rating And $9 PT https://acrobat.adobe.com/link/review?uri=urn...5cdb214ed7
November 9, 2023
P3 Health Partners Inc. Buy (PIII – $1.31) Price Target: $9 3Q A Bit Light But Primarily Due To The Timing Of Sweeps, Affirms Guidance For 2023, Sees $20M+ Of Positive AEBITDA For 2024; Affirm Buy Rating And $9 PT https://acrobat.adobe.com/link/review?uri=urn...5cdb214ed7
(0)
(0)
